Crane NXT (CXT) M&A Announcement summary
Event summary combining transcript, slides, and related documents.
M&A Announcement summary
8 Jul, 2026Deal rationale and strategic fit
Acquisition targets a global leader in inspection, detection, and track & trace technologies, expanding presence in the $2B track and trace and inspection technologies market and entering robust life sciences and food & beverage sectors with strong secular tailwinds from rising counterfeiting and regulatory demands.
Enhances technology offerings and authentication solutions, complementing and strengthening existing equipment, services, and software capabilities.
Aligns with strategy to diversify and grow in resilient, high-growth end markets, leveraging complementary capabilities and broadening end-market exposure.
Provides access to blue-chip customers, including most of the top 20 global pharma and food & beverage companies.
Combined portfolio offers a unique, fully integrated hardware and software solution, enhancing competitive differentiation.
Financial terms and conditions
Purchase price is €5.00 per share, implying an enterprise value of approximately €445M and an EV/EBITDA multiple of ~12x based on 2025 guidance, dropping to ~10x after synergies.
Acquirer to purchase approximately 30% stake at €5.00 per share, totaling about €120 million, with a mandatory tender offer for remaining shares at the same price.
Deal financed with cash and new/existing credit facilities; net leverage expected at ~2.9x at close.
EPS accretive in the first full year after closing and taking private (2027); double-digit ROIC expected by year five.
Synergies and expected cost savings
Low double-digit run-rate synergies targeted, mainly from productivity and operational improvements, to be realized over three to four years post-close.
Margin improvements expected, with EBITDA margins growing from mid-teens to low 20s over several years, driven by deployment of the Crane Business System.
Additional upside possible from combining authentication offerings and expanding integrated solutions.
Clear path to value creation by applying proven business systems to improve margins and growth.
Latest events from Crane NXT
- Q1 2025 sales up 5.3% to $330.3M; full-year sales growth guidance raised to 6–8%.CXT
Q1 20259 Jul 2026 - Sales up 11.4%, Adjusted EPS $4.06, 2026 outlook strong, dividend up 6%.CXT
Q4 20259 Jul 2026 - 2024 results met expectations; 2025 outlook sees modest growth, margin headwinds, and ongoing diversification.CXT
Q4 20248 Jul 2026 - Board and auditor approvals passed; strong 2025 results and growth-focused 2026 outlook shared.CXT
AGM 202626 May 2026 - Sales up 17% year-over-year, Adjusted EPS $0.60, and full-year sales guidance raised to 15%-17%.CXT
Q1 20267 May 2026 - Targets ~$2.5B revenue and $600M EBITDA by 2028 through growth, M&A, and innovation.CXT
Investor Day 202617 Apr 2026 - Board recommends electing nine directors, auditor ratification, and approving executive pay.CXT
Proxy filing7 Apr 2026 - Votes are sought for director elections, auditor ratification, and executive pay approval.CXT
Proxy filing7 Apr 2026 - Q3 2025 sales up 10% to $445.1M, SAT growth, and Antares Vision acquisition announced.CXT
Q3 20253 Feb 2026